City of Hope researchers unveil thymus regeneration therapy for immune system repair
Scientists at City of Hope, one of the most renowned cancer research and treatment institutions in the United States, have uncovered a novel method to ... Read More
Could a simple Vitamin D deficiency be the cause of your bone pain?
Vitamin D, scientifically known as calciferol, plays a vital role in maintaining bone health and supporting various physiological functions. As a fat-soluble vitamin, it is ... Read More
How Your Lymphatic System Keeps You Healthy: Must-Know Facts!
The lymphatic system forms an extensive network throughout our body and is crucial for maintaining fluid balance and immune function. Comprising lymph, lymph vessels, and ... Read More
The comprehensive health benefits of Turmeric: A deep dive
Turmeric, often hailed as the "Queen of Spices," holds a revered place not just in culinary traditions worldwide but also in the annals of medicinal ... Read More
Akthelia Pharmaceuticals gets EU Horizon Grant for IN-ARMOR project
Akthelia Pharmaceuticals, a preclinical drug development startup, and the University of Iceland have jointly secured a €6 million EU Horizon Grant for the IN-ARMOR project. ... Read More
Glenmark Pharmaceuticals set to begin clinical trial of GRC 54276 in US
Glenmark Pharmaceuticals, through its subsidiary Glenmark Specialty, is set to begin a first-in-human, phase 1/2 clinical study of GRC 54276 in the US for the ... Read More
FDA approves Janssen’s TECVAYLI for multiple myeloma treatment
The Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson, announced the US Food and Drug Administration's approval of its first bispecific T-cell engager antibody, ... Read More
Blender Bites launches Daily Defen-C superfood smoothie
Blender Bites, a Canadian manufacturer of organic and plant-based frozen functional foods, has launched a new superfood smoothie innovation called Daily Defen-C. According to Blender ... Read More
BriaCell Therapeutics gets license for anti-cancer agent sCD80 from UMBC
BriaCell Therapeutics has signed an exclusive licensing deal with the University of Maryland, Baltimore County (UMBC) to develop and commercialize Soluble CD80 (sCD80) as a ... Read More
Pfizer to acquire immuno-oncology company Trillium Therapeutics for $2.2bn
US pharma giant Pfizer has agreed to acquire Trillium Therapeutics, a publicly listed Canadian clinical stage immuno-oncology company, for $18.5 per share or $2.26 billion ... Read More